Ambu A/S, commonly referred to as Ambu, is a leading global provider of innovative medical devices headquartered in Denmark (DK). Founded in 1937, the company has established a strong presence in the healthcare industry, particularly in the fields of anaesthesia, patient monitoring, and emergency care. Ambu is renowned for its unique single-use endoscopy solutions and advanced airway management products, which enhance patient safety and streamline clinical workflows. With a commitment to quality and innovation, Ambu has achieved significant milestones, including the launch of its groundbreaking Ambu® aScope™. Today, Ambu operates in key markets across Europe, North America, and Asia, solidifying its position as a trusted partner in the medical community. The company’s dedication to improving patient outcomes and its robust product portfolio have earned it a notable reputation in the healthcare sector.
How does Ambu's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ambu's score of 79 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Ambu A/S reported total greenhouse gas emissions of approximately 209,157,000 kg CO2e, comprising 3,369,000 kg CO2e from Scope 1, 15,400,000 kg CO2e from Scope 2 (market-based), and a significant 190,388,000 kg CO2e from Scope 3 emissions. The previous year, 2023, saw total emissions of about 160,923,000 kg CO2e, with Scope 1 emissions at 3,945,000 kg CO2e, Scope 2 emissions at 16,168,000 kg CO2e (market-based), and Scope 3 emissions at 140,810,000 kg CO2e. Ambu has set ambitious climate commitments, aiming for a 75% reduction in absolute Scope 1 and 2 GHG emissions by FY2030, using FY2021 as the baseline. Additionally, the company is committed to ensuring that 82% of its suppliers, based on emissions from purchased goods and services, will have science-based targets by FY2027. Furthermore, Ambu has pledged to achieve net-zero emissions across all scopes by 2045. These targets align with the Science Based Targets initiative (SBTi) and reflect Ambu's commitment to sustainable practices within the healthcare equipment and supplies sector. The company is actively working towards these goals, demonstrating a proactive approach to reducing its carbon footprint and contributing to global climate efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,337,000 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,886,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ambu has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Ambu's sustainability data and climate commitments